Page 85 - TD-4-1

Tumor Discovery Colorectal cancer: miRNA, mRNA, protein insights

doi: 10.1046/j.1525-1438.2000.010004305.x 2023;15(4):1367.
5. Coleman D, Kuwada S. miRNA as a Biomarker for the early doi: 10.3390/cancers15051367
detection of colorectal cancer. Genes (Basel). 2024;15(3):338.
16. Li T, Lai Q, Wang S, et al. MicroRNA-224 sustains Wnt/β-
doi: 10.3390/genes15030338 catenin signaling and promotes aggressive phenotype of
colorectal cancer. J Exp Clin Cancer Res. 2016;35:21.
6. Kral J, Kojecky V, Stepan M, et al. The experience with
colorectal cancer screening in the Czech Republic: The doi: 10.1186/s13046-016-0287-1. Erratum in: J Exp Clin
detection at earlier stages and improved clinical outcomes. Cancer Res. 2021;40(1):143.
Public Health. 2020;185:153-158.
doi: 10.1186/s13046-021-01945-3
doi: 10.1016/j.puhe.2020.05.021
17. Sun D, Yu F, Ma Y, et al. MicroRNA-31 activates the RAS
7. Ji Y, Jialin G, Hongqun Z, Houxi X. Identification and pathway and functions as an oncogenic MicroRNA in human
validation of Key miRNAs for colon cancer based colorectal cancer by repressing RAS p21 GTPase activating
on miRNA-gene integration analysis. Int J Gen Med. protein 1 (RASA1). J Biol Chem. 2013;288(13):9508-9518.
2023;(16):5703-5718.
doi: 10.1074/jbc.M112.367763
doi: 10.2147/IJGM.S440340
18. Zhang G, Zhou H, Xiao H, Liu Z, Tian H, Zhou T.
8. Sadeghi S, Lotfi M, Soltani N, et al. Recent advances on high- MicroRNA-92a functions as an oncogene in colorectal
efficiency of microRNAs in different types of lung cancer: cancer by targeting PTEN. Dig Dis Sci. 2014;59(1):98-107.
A comprehensive review. Cancer Cell Int. 2023;23(1):284.
doi: 10.1007/s10620-013-2858-8
doi: 10.1186/s12935-023-03133-z
19. Mo WY, Cao SQ. MiR-29a-3p: A potential biomarker and
9. Sado AI, Batool W, Ahmed A, et al. Role of microRNA in therapeutic target in colorectal cancer. Clin Transl Oncol.
colorectal carcinoma (CRC): A narrative review. Ann Med 2023;25(3):563-577.
Surg (Lond). 2023;86(1):308-318.
doi: 10.1007/s12094-022-02978-6
doi: 10.1097/MS9.0000000000001494
20. Sokolova V, Fiorino A, Zoni E, et al. The effects of miR-
10. Koncina E, Haan S, Rauh S, Letellier E. Prognostic and 20a on p21: Two mechanisms blocking growth arrest
predictive molecular biomarkers for colorectal cancer: in TGF-β-responsive colon carcinoma. J Cell Physiol.
Updates and challenges. Cancers (Basel). 2020;12(2):319. 2015;230(12):3105-3114.
doi: 10.3390/cancers12020319 doi: 10.1002/jcp.25051
11. Cheng D, Zhao S, Tang H, et al. MicroRNA-20a-5p promotes 21. Michas A, Michas V, Anagnostou E. The clinical significance
colorectal cancer invasion and metastasis by downregulating of MicroRNAs in colorectal cancer signaling pathways:
Smad4. Oncotarget. 2016;7(29):45199-45213. A review. Glob Med Genet. 2023;10(4):315-323.
doi: 10.18632/oncotarget.9900 doi: 10.1055/s-0043-1777094
12. Sun LH, Tian D, Yang ZC, Li JL. Exosomal miR-21 22. Chretien AS, Harlé A, Meyer-Lefebvre M, et al. Optimization
promotes proliferation, invasion and therapy resistance of of routine KRAS mutation PCR-based testing procedure for
colon adenocarcinoma cells through its target PDCD4. Sci rational individualized first-line-targeted therapy selection
Rep. 2020;10(1):8271. in metastatic colorectal cancer. Cancer Med. 2013;2(1):11-20.
doi: 10.1038/s41598-020-65207-6 doi: 10.1002/cam4.47
13. Wang J, Chen X, Xie C, et al. MicroRNA miR-29a inhibits 23. Díaz R, Silva J, García JM, et al. Deregulated expression of
colon cancer progression by downregulating B7-H3 miR-106a predicts survival in human colon cancer patients.
expression: Potential molecular targets for colon cancer Genes Chromosomes Cancer. 2008;47(9):794-802.
therapy. Mol Biotechnol. 2021;63(9):849-861
doi: 10.1002/gcc.20580
doi: 10.1007/s12033-021-00348-1
24. Ng EK, Chong WW, Jin H, et al. Differential expression of
14. Kent OA, Mendell JT, Rottapel R. Transcriptional regulation microRNAs in plasma of patients with colorectal cancer:
of miR-31 by Oncogenic KRAS mediates metastatic A potential marker for colorectal cancer screening. Gut.
phenotypes by repressing RASA1. Mol Cancer Res. 2009;58(10):1375-1381.
2016;14(3):267-277.
doi: 10.1136/gut.2008.167817
doi: 10.1158/1541-7786.MCR-15-0456
25. Abd El-Rehim DM, Ball G, Pinder SE, et al. High-
15. Li Y, Li K, Lou X, et al. HNRNPA2B1-mediated microRNA- throughput protein expression analysis using tissue
92a upregulation and section acts as a promising noninvasive microarray technology of a large well-characterised series
diagnostic biomarker in colorectal cancer. Cancers (Basel). identifies biologically distinct classes of breast cancer

Volume 4 Issue 1 (2025) 77 doi: 10.36922/td.4631